KPL (Part of LGC Clinical Diagnostics) Email Format
Biotechnology ResearchMaryland, United States51-200 Employees
KPL is a portfolio within LGC Clinical Diagnostics that operates in the biotechnology research sector, offering more than 800 reagents and kits for immunoassays, immunohistochemistry, infectivity assays, and flow cytometry. Its product line includes the BacTrace range of native bacterial antigens and polyclonal antibodies, as well as secondary antibodies, substrates, and washing buffers. These reagents are designed to maximize signal-to-noise ratios, supporting sensitivity and specificity across diverse applications. Based in Gaithersburg, Maryland, the company is part of LGC's Clinical Diagnostics organization. Its customers are researchers and diagnostic developers in biotechnology and related life-science fields who rely on reagents for assay development and validation. A recent development includes the December 2023 launch of the ACCURUN Babesia Positive Molecular Control Kit.